Application 212832
- Type
- NDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | SOLUTION;INTRAVENOUS | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | Yes | Yes |
| 002 | POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | SOLUTION;INTRAVENOUS | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | Yes | Yes |
| 003 | POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | SOLUTION;INTRAVENOUS | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | Yes | Yes |
| 004 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | SOLUTION;INTRAVENOUS | 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML) | Yes | Yes |
| 005 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | SOLUTION;INTRAVENOUS | 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N212832-001 | POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 |
| N212832-002 | POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 |
| N212832-003 | POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 |
| N212832-004 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-05-09 | |
| N212832-005 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-05-09 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N212832-001 | AP |
| N212832-002 | AP |
| N212832-003 | AP |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N212832-004 | 11813291 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 |
| N212832-004 | 11925661 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 |
| N212832-005 | 11813291 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 |
| N212832-005 | 11925661 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212832-004 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-05-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212832-005 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-05-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-004 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-05-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-005 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-05-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML(236MG/ML); 1.12GM/5ML(224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML(236MG/ML); 3.36GM/15ML(224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML(236MG/ML); 11.2GM/50ML(224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-004 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | 1.18GM/100ML(11.8MG/ML); 1.12GM/100ML(11.2MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-05-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-005 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | 1.18GM/250ML(4.72MG/ML); 1.12GM/250ML(4.48MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-05-09 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212832-002 | POTASSIUM PHOSPHATES | 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212832-003 | POTASSIUM PHOSPHATES | 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212832-001 | POTASSIUM PHOSPHATES | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2019-11-26 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N212832-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212832-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212832-003 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-003 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-003 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212832-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212832-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212832-003 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212832-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212832-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212832-003 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212832-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212832-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212832-003 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212832-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212832-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212832-003 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212832-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212832-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212832-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212832-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212832-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212832-003 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N212832-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212832-002 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212832-003 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212832-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212832-002 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212832-003 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212832-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212832-002 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212832-003 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212832-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212832-002 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212832-003 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N212832-001 | AP | 1 | 8072bd15b7f6… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N212832-004 | 11813291 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212832-004 | 11925661 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212832-005 | 11813291 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212832-005 | 11925661 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-004 | 11813291 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-004 | 11925661 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-005 | 11813291 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212832-005 | 11925661 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-004 | 11813291 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-004 | 11925661 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-005 | 11813291 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212832-005 | 11925661 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212832-004 | 11813291 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212832-004 | 11925661 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212832-005 | 11813291 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212832-005 | 11925661 | 2041-10-12 | U-4185 | Drug product | 2025-05-22 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Phosphates | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC | CIVICA, INC. | f7702b2f-d0d1-4696-896d-571607fc0dc8 | 2026-07-10 | Warnings, Adverse reactions | 212832 NDA212832 |
| Potassium Phosphates | POTASSIUM PHOSPHATES | Fresenius Kabi USA, LLC | 357c3020-ea6f-4401-a2e7-cebb82b03144 | 2025-04-15 | Warnings, Adverse reactions | 212832 NDA212832 |
| Potassium Phosphates | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC | Fresenius Kabi USA, LLC | 475f5cd7-45bd-412a-b419-9962585d6cda | 2025-02-28 | Warnings, Adverse reactions | 212832 NDA212832 65219-056 65219-052 65219-054 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65219-052 | Potassium Phosphates | Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic | Fresenius Kabi USA, LLC | NDA | Current |
| 65219-052 | Potassium Phosphates | Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic | Fresenius Kabi USA, LLC | NDA | Current |
| 65219-054 | Potassium Phosphates | Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic | Fresenius Kabi USA, LLC | NDA | Current |
| 65219-054 | Potassium Phosphates | Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic | Fresenius Kabi USA, LLC | NDA | Current |
| 65219-056 | Potassium Phosphates | Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic | Fresenius Kabi USA, LLC | NDA | Current |
| 65219-056 | Potassium Phosphates | Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic | Fresenius Kabi USA, LLC | NDA | Current |